The Latest in Bleeding Disorders

Review reveals lack of data on mild hemophilia A

August 13, 2019

Bleeding Disorders

RNA interference drug fitusiran looks effective in both hemophilia A and B

July 29, 2019

Bleeding Disorders

Early phase trial shows durable responses to gene therapy for hemophilia A

July 29, 2019

Bleeding Disorders

Emicizumab follow-up shows further bleeding declines

July 21, 2019

Bleeding Disorders

Minor surgeries appear safe for hemophilia patients on emicizumab

July 18, 2019

Bleeding Disorders

rFVIII product shows better PK profile than rFVIIIFc

July 2, 2019

Bleeding Disorders

FDA expands Doptelet approval to ITP patients with thrombocytopenia

June 27, 2019

Day 75 is key threshold in FVIII inhibitor development

June 25, 2019

Bleeding Disorders

Rozanolixizumab may offer new treatment paradigm for ITP

June 25, 2019

Bleeding Disorders

Platelet glycoprotein genotypes predict responses to ITP therapy

June 21, 2019

Bleeding Disorders

Past donor pregnancy, sex do not affect transfusion-related mortality

June 11, 2019

Bleeding Disorders

FDA: Faulty hematology analyzers face class I recall

May 24, 2019

FVIII/W ratio may help predict relapse in hemophilia A

May 22, 2019

Bleeding Disorders

Novel chromogenic assay looks accurate in hemophilia A diagnosis

May 22, 2019

Bleeding Disorders

Low-dose FVIII prophylaxis reduced bleeding in hemophilia A

May 22, 2019